RYGB and Drug Disposition: How to Do Better? Analysis of Pharmacokinetic Studies and Recommendations for Clinical Practice.
about
Pharmacokinetics of tedizolid in obese patient after bariatric surgery: a case report.Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL).
P2860
RYGB and Drug Disposition: How to Do Better? Analysis of Pharmacokinetic Studies and Recommendations for Clinical Practice.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
RYGB and Drug Disposition: How ...... dations for Clinical Practice.
@en
RYGB and Drug Disposition: How ...... dations for Clinical Practice.
@nl
type
label
RYGB and Drug Disposition: How ...... dations for Clinical Practice.
@en
RYGB and Drug Disposition: How ...... dations for Clinical Practice.
@nl
prefLabel
RYGB and Drug Disposition: How ...... dations for Clinical Practice.
@en
RYGB and Drug Disposition: How ...... dations for Clinical Practice.
@nl
P2093
P2860
P1433
P1476
RYGB and Drug Disposition: How ...... ndations for Clinical Practice
@en
P2093
Claire Carette
Célia Lloret-Linares
Lorry Hachon
Pauline Faucher
P2860
P2888
P304
P356
10.1007/S11695-016-2535-Z
P577
2017-04-01T00:00:00Z